Urayama O, Nagamune H, Nakao M, Hara Y, Sugiyama H, Sato K, Nakao T
J Biochem. 1985 Jul;98(1):209-17. doi: 10.1093/oxfordjournals.jbchem.a135260.
A hybridoma cell line producing mouse monoclonal antibody against pig kidney Na,K-ATPase was established. The antibody, named 38 (mAb38, IgG1), was purified from mouse ascites fluid by chromatography on a protein A-Sepharose column. Antigens immobilized on microplate wells with p-benzoquinone were used for titer assays. mAb38 cross-reacted with both dodecyloctaethyleneglycol monoether (C12E8)-solubilized enzyme and membranous sodium dodecyl sulfate (SDS)-treated enzyme from kidney with high affinity (50% binding = 0.6 nM). However, the antibody bound to neither alpha- nor beta-subunit separated by preparative SDS-polyacrylamide gel electrophoresis (PAGE). The stoichiometry of antibody binding to the purified enzyme was estimated to be about 0.86 mol of IgG per mol of alpha beta-protomer. Na,K-ATPase proteins were recovered from a column of mAb38-coupled Affi-Gel by elution with pH 3 buffer when C12E8-solubilized kidney enzyme or detergent extracts of brain microsomes were applied to it, confirming that the mAb is directed to Na,K-ATPase. mAb38 at saturation level concentrations had no effect on kidney Na,K-ATPase activity or on ouabain-sensitive Rb uptake in erythrocytes. In an immunofluorescence study, the antibody bound to intact erythrocytes much more strongly than control IgG1 (mAb50c), but the extent of the antibody binding to inside-out vesicles under hypotonic conditions was lower than that of the control. Most of the antibody binding activity remained when the kidney enzyme was treated with sialidase. These results suggest that this mAb38 was raised against an intact conformation of a cell-surface-exposed site of Na,K-ATPase.
建立了一种产生抗猪肾钠钾ATP酶小鼠单克隆抗体的杂交瘤细胞系。该抗体命名为38(单克隆抗体38,IgG1),通过蛋白A-琼脂糖柱层析从小鼠腹水中纯化得到。用对苯醌固定在微孔板孔上的抗原进行效价测定。单克隆抗体38与十二烷基八乙二醇单醚(C12E8)增溶的酶以及肾脏经十二烷基硫酸钠(SDS)处理的膜状酶都有高亲和力交叉反应(50%结合 = 0.6 nM)。然而,该抗体与通过制备性SDS-聚丙烯酰胺凝胶电泳(PAGE)分离的α亚基和β亚基均不结合。估计抗体与纯化酶结合的化学计量比约为每摩尔αβ原聚体0.86摩尔IgG。当将C12E8增溶的肾脏酶或脑微粒体的去污剂提取物应用于偶联有单克隆抗体38的Affi-Gel柱时,通过用pH 3缓冲液洗脱可从该柱中回收钠钾ATP酶蛋白,证实该单克隆抗体针对的是钠钾ATP酶。饱和浓度的单克隆抗体38对肾脏钠钾ATP酶活性或红细胞中哇巴因敏感的铷摄取没有影响。在免疫荧光研究中,该抗体与完整红细胞的结合比对照IgG1(单克隆抗体50c)强得多,但在低渗条件下与外翻囊泡的抗体结合程度低于对照。用唾液酸酶处理肾脏酶后,大部分抗体结合活性仍然保留。这些结果表明,该单克隆抗体38是针对钠钾ATP酶细胞表面暴露位点的完整构象产生的。